Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
23m
Lilly’s Kisunla does not demonstrate “good value” for UK’s NHS
The UK’s National Institute of Health and Care Excellence (NICE) said the drug provided only a small benefit to patients.
pharmaphorum
19m
UK launches scheme to boost dementia trial participation
The Dementia Trials Accelerator (DTA) – which will be spearheaded by the UK Dementia Research Institute (UK DRI) and Health ...
20m
on MSN
New Alzheimer’s drug approved in UK, but government won’t pay for it
The drug is the second Alzheimer’s medicine to receive a lukewarm reception from the UK government in recent months. View on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Workers reject new contract
Settles civil lawsuit
NK troops in RU confirmed
Joins Republican Party
Suffers 'debilitating' stroke
'Tarzan' star Ron Ely dies
Court orders new sentence
Closing argument speech plan
Yelp disables reviews
FDA recalls antidepressant
MO court upholds release
Biden says lock up Trump
Dodgers legend dies
G7 Ukraine loan advances
Hashem Safieddine killed
DNC office shootings arrest
Bird flu infects 4 in WA
Timberlake postpones shows
Kentucky lawmaker dies
Israel strikes Lebanese city
Existing home sales fall
Apple, Goldman Sachs fined
DOJ alleges racial bias
US fines American Airlines
First father-son duo in NBA
Settles hazardous waste suit
$3.9B storm relief proposal
Lake Erie toxic algae study
To close 150 locations
Related topics
Alzheimer
Eli Lilly and Company
United Kingdom
National Health Service
NHS
Feedback